Literature DB >> 36215479

Bip-Yorkie interaction determines oncogenic and tumor-suppressive roles of Ire1/Xbp1s activation.

Shuai Yang1,2,3,4, Hua Jiang3,4,5, Weixiang Bian3,4,5, Wenyan Xu2,3,4, Yifan Guo2,3,4, Sha Song2,3,4, Jiadong Zheng2,3,4, Xiaoyu Kuang2,3,4, Chenxi Wu6, Xiang Ding7, Xiaowei Guo8, Lei Xue7, Zijing Yu3,9, Yongdeng Zhang3,9, Hyung Don Ryoo10, Xu Li3,4,5, Xianjue Ma2,3,4.   

Abstract

Unfolded protein response (UPR) is the mechanism by which cells control endoplasmic reticulum (ER) protein homeostasis. ER proteostasis is essential to adapt to cell proliferation and regeneration in development and tumorigenesis, but mechanisms linking UPR, growth control, and cancer progression remain unclear. Here, we report that the Ire1/Xbp1s pathway has surprisingly oncogenic and tumor-suppressive roles in a context-dependent manner. Activation of Ire1/Xbp1s up-regulates their downstream target Bip, which sequesters Yorkie (Yki), a Hippo pathway transducer, in the cytoplasm to restrict Yki transcriptional output. This regulation provides an endogenous defensive mechanism in organ size control, intestinal homeostasis, and regeneration. Unexpectedly, Xbp1 ablation promotes tumor overgrowth but suppresses invasiveness in a Drosophila cancer model. Mechanistically, hyperactivated Ire1/Xbp1s signaling in turn induces JNK-dependent developmental and oncogenic cell migration and epithelial-mesenchymal transition (EMT) via repression of Yki. In humans, a negative correlation between XBP1 and YAP (Yki ortholog) target gene expression specifically exists in triple-negative breast cancers (TNBCs), and those with high XBP1 or HSPA5 (Bip ortholog) expression have better clinical outcomes. In human TNBC cell lines and xenograft models, ectopic XBP1s or HSPA5 expression alleviates tumor growth but aggravates cell migration and invasion. These findings uncover a conserved crosstalk between the Ire1/Xbp1s and Hippo signaling pathways under physiological settings, as well as a crucial role of Bip-Yki interaction in tumorigenesis that is shared from Drosophila to humans.

Entities:  

Keywords:  Hippo signaling; size control; triple-negative breast cancer; tumorigenesis; unfolded protein response

Mesh:

Substances:

Year:  2022        PMID: 36215479      PMCID: PMC9586321          DOI: 10.1073/pnas.2202133119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  46 in total

1.  Myc suppresses tumor invasion and cell migration by inhibiting JNK signaling.

Authors:  X Ma; J Huang; Y Tian; Y Chen; Y Yang; X Zhang; F Zhang; L Xue
Journal:  Oncogene       Date:  2017-01-09       Impact factor: 9.867

Review 2.  Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control.

Authors:  Hans Clevers; Kyle M Loh; Roel Nusse
Journal:  Science       Date:  2014-10-02       Impact factor: 47.728

3.  The endoplasmic reticulum-residing chaperone BiP is short-lived and metabolized through N-terminal arginylation.

Authors:  Sang Mi Shim; Ha Rim Choi; Ki Woon Sung; Yoon Jee Lee; Sung Tae Kim; Daeho Kim; Su Ran Mun; Joonsung Hwang; Hyunjoo Cha-Molstad; Aaron Ciechanover; Bo Yeon Kim; Yong Tae Kwon
Journal:  Sci Signal       Date:  2018-01-02       Impact factor: 8.192

4.  Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis.

Authors:  Hongtan Wu; Luyao Wei; Fuqin Fan; Suyuan Ji; Shihao Zhang; Jing Geng; Lixin Hong; Xin Fan; Qinghua Chen; Jing Tian; Mingting Jiang; Xiufeng Sun; Changnan Jin; Zhen-Yu Yin; Qingxu Liu; Jinjia Zhang; Funiu Qin; Kwang-Huei Lin; Jau-Song Yu; Xianming Deng; Hong-Rui Wang; Bin Zhao; Randy L Johnson; Lanfen Chen; Dawang Zhou
Journal:  Nat Commun       Date:  2015-02-19       Impact factor: 14.919

Review 5.  The Hippo Signaling Pathway in Development and Disease.

Authors:  Yonggang Zheng; Duojia Pan
Journal:  Dev Cell       Date:  2019-08-05       Impact factor: 12.270

6.  Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice.

Authors:  Iván M Moya; Stéphanie A Castaldo; Laura Van den Mooter; Soheil Soheily; Leticia Sansores-Garcia; Jelle Jacobs; Inge Mannaerts; Jun Xie; Elisabeth Verboven; Hanne Hillen; Ana Algueró-Nadal; Ruchan Karaman; Matthias Van Haele; Weronika Kowalczyk; Maxime De Waegeneer; Stefaan Verhulst; Panagiotis Karras; Leen van Huffel; Lars Zender; Jean-Christophe Marine; Tania Roskams; Randy Johnson; Stein Aerts; Leo A van Grunsven; Georg Halder
Journal:  Science       Date:  2019-11-22       Impact factor: 47.728

7.  TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1.

Authors:  Jie Su; Sophie M Morgani; Charles J David; Qiong Wang; Ekrem Emrah Er; Yun-Han Huang; Harihar Basnet; Yilong Zou; Weiping Shu; Rajesh K Soni; Ronald C Hendrickson; Anna-Katerina Hadjantonakis; Joan Massagué
Journal:  Nature       Date:  2020-01-08       Impact factor: 49.962

Review 8.  Tumour-host interactions through the lens of Drosophila.

Authors:  David Bilder; Katy Ong; Tsai-Ching Hsi; Kavya Adiga; Jung Kim
Journal:  Nat Rev Cancer       Date:  2021-08-13       Impact factor: 60.716

9.  Fast, three-dimensional super-resolution imaging of live cells.

Authors:  Sara A Jones; Sang-Hee Shim; Jiang He; Xiaowei Zhuang
Journal:  Nat Methods       Date:  2011-05-08       Impact factor: 28.547

10.  A Balance of Yki/Sd Activator and E2F1/Sd Repressor Complexes Controls Cell Survival and Affects Organ Size.

Authors:  Peng Zhang; Chunli Pei; Xi Wang; Jinyi Xiang; Bao-Fa Sun; Yongsheng Cheng; Xiaolong Qi; Marco Marchetti; Jia-Wei Xu; Ying-Pu Sun; Bruce A Edgar; Zengqiang Yuan
Journal:  Dev Cell       Date:  2017-12-04       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.